ID;Description;GeneRatio;BgRatio;pvalue;p.adjust;qvalue;geneID;Count
GO:0060337;type I interferon signaling pathway;8/8;95/18862;3.06352671664824e-19;4.86265240660706e-17;2.21629301223545e-17;MX1/STAT1/IFIT2/IFI6/XAF1/IFI35/IRF1/IFI27;8
GO:0071357;cellular response to type I interferon;8/8;96/18862;3.34202914543441e-19;4.86265240660706e-17;2.21629301223545e-17;MX1/STAT1/IFIT2/IFI6/XAF1/IFI35/IRF1/IFI27;8
GO:0034340;response to type I interferon;8/8;101/18862;5.09354241578531e-19;4.94073614331175e-17;2.25188191013666e-17;MX1/STAT1/IFIT2/IFI6/XAF1/IFI35/IRF1/IFI27;8
GO:0051607;defense response to virus;6/8;260/18862;1.77213528080353e-10;1.03138273342765e-08;4.7008220080262e-09;MX1/STAT1/IFIT2/IFI6/IRF1/IFI27;6
GO:0140546;defense response to symbiont;6/8;260/18862;1.77213528080353e-10;1.03138273342765e-08;4.7008220080262e-09;MX1/STAT1/IFIT2/IFI6/IRF1/IFI27;6
GO:0009615;response to virus;6/8;359/18862;1.23667502857785e-09;5.99787388860259e-08;2.73370269475104e-08;MX1/STAT1/IFIT2/IFI6/IRF1/IFI27;6
GO:0035456;response to interferon-beta;3/8;31/18862;2.23849250375569e-07;9.3057331227558e-06;4.24135421764236e-06;STAT1/XAF1/IRF1;3
GO:0035458;cellular response to interferon-beta;2/8;22/18862;3.62080337989694e-05;0.00131706722943751;0.000600291086667124;STAT1/IRF1;2
GO:0045088;regulation of innate immune response;3/8;315/18862;0.000242778407972516;0.00784983519111137;0.00357778706485814;STAT1/IFI35/IRF1;3
GO:0032481;positive regulation of type I interferon production;2/8;77/18862;0.000453312408892488;0.0119921737261558;0.00546577641344052;STAT1/IRF1;2
GO:0034121;regulation of toll-like receptor signaling pathway;2/8;77/18862;0.000453312408892488;0.0119921737261558;0.00546577641344052;IFI35/IRF1;2
GO:0002831;regulation of response to biotic stimulus;3/8;420/18862;0.000564807283605134;0.0131477397870063;0.00599245872006797;STAT1/IFI35/IRF1;3
GO:0048525;negative regulation of viral process;2/8;89/18862;0.000605144894089465;0.0131477397870063;0.00599245872006797;MX1/STAT1;2
GO:0060333;interferon-gamma-mediated signaling pathway;2/8;91/18862;0.000632537309340508;0.0131477397870063;0.00599245872006797;STAT1/IRF1;2
GO:0062207;regulation of pattern recognition receptor signaling pathway;2/8;105/18862;0.000840879188223088;0.0163130562515279;0.0074351422958673;IFI35/IRF1;2
GO:0008637;apoptotic mitochondrial changes;2/8;118/18862;0.0010601799328007;0.0192820225278127;0.00878833365347946;IFIT2/IFI6;2
GO:0032479;regulation of type I interferon production;2/8;128/18862;0.00124566929783185;0.0193747392886511;0.0088305919709533;STAT1/IRF1;2
GO:0019079;viral genome replication;2/8;129/18862;0.00126501734187069;0.0193747392886511;0.0088305919709533;MX1/IFI27;2
GO:0032606;type I interferon production;2/8;129/18862;0.00126501734187069;0.0193747392886511;0.0088305919709533;STAT1/IRF1;2
GO:0002224;toll-like receptor signaling pathway;2/8;157/18862;0.00186524975696133;0.0271393839637874;0.0123695510198488;IFI35/IRF1;2
GO:0071346;cellular response to interferon-gamma;2/8;177/18862;0.00236239412105255;0.0327360328202997;0.0149203839224372;STAT1/IRF1;2
GO:0050792;regulation of viral process;2/8;186/18862;0.00260447440133993;0.0344500932177237;0.0157016160080781;MX1/STAT1;2
GO:0034341;response to interferon-gamma;2/8;197/18862;0.00291569387498213;0.0353527882341583;0.0161130450985854;STAT1/IRF1;2
GO:0043903;regulation of biological process involved in symbiotic interaction;2/8;197/18862;0.00291569387498213;0.0353527882341583;0.0161130450985854;MX1/STAT1;2
GO:0002221;pattern recognition receptor signaling pathway;2/8;208/18862;0.00324367528979408;0.0377563803732031;0.0172085510111181;IFI35/IRF1;2
GO:0097191;extrinsic apoptotic signaling pathway;2/8;217/18862;0.00352440535506745;0.0394462291663318;0.0179787479651214;IFI6/IFI27;2
GO:0071104;response to interleukin-9;1/8;10/18862;0.00423425428167612;0.0410646466511324;0.0187163880558607;STAT1;1
GO:0072203;cell proliferation involved in metanephros development;1/8;10/18862;0.00423425428167612;0.0410646466511324;0.0187163880558607;STAT1;1
GO:0034145;positive regulation of toll-like receptor 4 signaling pathway;1/8;11/18862;0.00465681559961295;0.0410646466511324;0.0187163880558607;IFI35;1
GO:0035457;cellular response to interferon-alpha;1/8;11/18862;0.00465681559961295;0.0410646466511324;0.0187163880558607;IFIT2;1
GO:0070106;interleukin-27-mediated signaling pathway;1/8;11/18862;0.00465681559961295;0.0410646466511324;0.0187163880558607;STAT1;1
GO:0070142;synaptic vesicle budding;1/8;11/18862;0.00465681559961295;0.0410646466511324;0.0187163880558607;MX1;1
GO:0070757;interleukin-35-mediated signaling pathway;1/8;11/18862;0.00465681559961295;0.0410646466511324;0.0187163880558607;STAT1;1
GO:0003337;mesenchymal to epithelial transition involved in metanephros morphogenesis;1/8;12/18862;0.00507922000655159;0.0434721477031327;0.0198136755673529;STAT1;1
GO:0072182;regulation of nephron tubule epithelial cell differentiation;1/8;13/18862;0.00550146755243774;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0043374;CD8-positive, alpha-beta T cell differentiation;1/8;14/18862;0.00592355828720226;0.0440983680830508;0.0200990934290628;IRF1;1
GO:0072075;metanephric mesenchyme development;1/8;15/18862;0.00634549226076486;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0072160;nephron tubule epithelial cell differentiation;1/8;15/18862;0.00634549226076486;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0072283;metanephric renal vesicle morphogenesis;1/8;15/18862;0.00634549226076486;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0090148;membrane fission;1/8;15/18862;0.00634549226076486;0.0440983680830508;0.0200990934290628;MX1;1
GO:0002281;macrophage activation involved in immune response;1/8;18/18862;0.00761035411322508;0.0440983680830508;0.0200990934290628;IFI35;1
GO:0007221;positive regulation of transcription of Notch receptor target;1/8;18/18862;0.00761035411322508;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0072077;renal vesicle morphogenesis;1/8;18/18862;0.00761035411322508;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0098884;postsynaptic neurotransmitter receptor internalization;1/8;18/18862;0.00761035411322508;0.0440983680830508;0.0200990934290628;MX1;1
GO:0140239;postsynaptic endocytosis;1/8;18/18862;0.00761035411322508;0.0440983680830508;0.0200990934290628;MX1;1
GO:2000696;regulation of epithelial cell differentiation involved in kidney development;1/8;18/18862;0.00761035411322508;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0044827;modulation by host of viral genome replication;1/8;19/18862;0.00803166154089929;0.0440983680830508;0.0200990934290628;IFI27;1
GO:0051900;regulation of mitochondrial depolarization;1/8;19/18862;0.00803166154089929;0.0440983680830508;0.0200990934290628;IFI6;1
GO:0060231;mesenchymal to epithelial transition;1/8;19/18862;0.00803166154089929;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0072074;kidney mesenchyme development;1/8;19/18862;0.00803166154089929;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0072087;renal vesicle development;1/8;19/18862;0.00803166154089929;0.0440983680830508;0.0200990934290628;STAT1;1
GO:0072234;metanephric nephron tubule development;1/8;19/18862;0.00803166154089929;0.0440983680830508;0.0200990934290628;STAT1;1
GO:2001185;regulation of CD8-positive, alpha-beta T cell activation;1/8;19/18862;0.00803166154089929;0.0440983680830508;0.0200990934290628;IRF1;1
GO:0019058;viral life cycle;2/8;348/18862;0.00883019168532179;0.0443400275599012;0.0202092366523695;MX1/IFI27;2
GO:0002053;positive regulation of mesenchymal cell proliferation;1/8;21/18862;0.00887380691066353;0.0443400275599012;0.0202092366523695;STAT1;1
GO:0035455;response to interferon-alpha;1/8;21/18862;0.00887380691066353;0.0443400275599012;0.0202092366523695;IFIT2;1
GO:0072111;cell proliferation involved in kidney development;1/8;21/18862;0.00887380691066353;0.0443400275599012;0.0202092366523695;STAT1;1
GO:0072170;metanephric tubule development;1/8;21/18862;0.00887380691066353;0.0443400275599012;0.0202092366523695;STAT1;1
GO:0032727;positive regulation of interferon-alpha production;1/8;22/18862;0.00929464495241916;0.0443400275599012;0.0202092366523695;STAT1;1
GO:0051882;mitochondrial depolarization;1/8;22/18862;0.00929464495241916;0.0443400275599012;0.0202092366523695;IFI6;1
GO:0072243;metanephric nephron epithelium development;1/8;22/18862;0.00929464495241916;0.0443400275599012;0.0202092366523695;STAT1;1
GO:0060330;regulation of response to interferon-gamma;1/8;25/18862;0.0105562211028924;0.0458486618051;0.020896839889465;STAT1;1
GO:0060334;regulation of interferon-gamma-mediated signaling pathway;1/8;25/18862;0.0105562211028924;0.0458486618051;0.020896839889465;STAT1;1
GO:0072202;cell differentiation involved in metanephros development;1/8;25/18862;0.0105562211028924;0.0458486618051;0.020896839889465;STAT1;1
GO:0072207;metanephric epithelium development;1/8;25/18862;0.0105562211028924;0.0458486618051;0.020896839889465;STAT1;1
GO:0072273;metanephric nephron morphogenesis;1/8;25/18862;0.0105562211028924;0.0458486618051;0.020896839889465;STAT1;1
GO:0099590;neurotransmitter receptor internalization;1/8;25/18862;0.0105562211028924;0.0458486618051;0.020896839889465;MX1;1
GO:0010464;regulation of mesenchymal cell proliferation;1/8;26/18862;0.0109764339940731;0.0462919172793518;0.0210988662586302;STAT1;1
GO:0034143;regulation of toll-like receptor 4 signaling pathway;1/8;26/18862;0.0109764339940731;0.0462919172793518;0.0210988662586302;IFI35;1
GO:0034123;positive regulation of toll-like receptor signaling pathway;1/8;27/18862;0.0113964907220434;0.0467095605649948;0.0212892191397697;IFI35;1
GO:0036037;CD8-positive, alpha-beta T cell activation;1/8;27/18862;0.0113964907220434;0.0467095605649948;0.0212892191397697;IRF1;1
GO:0032607;interferon-alpha production;1/8;28/18862;0.0118163913365495;0.0470795853973604;0.0214578685479017;STAT1;1
GO:0032647;regulation of interferon-alpha production;1/8;28/18862;0.0118163913365495;0.0470795853973604;0.0214578685479017;STAT1;1
GO:1903706;regulation of hemopoiesis;2/8;415/18862;0.0123853471695066;0.0470795853973604;0.0214578685479017;STAT1/IRF1;2
GO:0070102;interleukin-6-mediated signaling pathway;1/8;30/18862;0.0126557244240907;0.0470795853973604;0.0214578685479017;STAT1;1
GO:0090183;regulation of kidney development;1/8;30/18862;0.0126557244240907;0.0470795853973604;0.0214578685479017;STAT1;1
GO:0002230;positive regulation of defense response to virus by host;1/8;31/18862;0.0130751569965525;0.0470795853973604;0.0214578685479017;STAT1;1
GO:0003338;metanephros morphogenesis;1/8;31/18862;0.0130751569965525;0.0470795853973604;0.0214578685479017;STAT1;1
GO:0044788;modulation by host of viral process;1/8;31/18862;0.0130751569965525;0.0470795853973604;0.0214578685479017;IFI27;1
GO:0045648;positive regulation of erythrocyte differentiation;1/8;32/18862;0.0134944336544056;0.0470795853973604;0.0214578685479017;STAT1;1
GO:0046825;regulation of protein export from nucleus;1/8;32/18862;0.0134944336544056;0.0470795853973604;0.0214578685479017;IFI27;1
GO:1901099;negative regulation of signal transduction in absence of ligand;1/8;32/18862;0.0134944336544056;0.0470795853973604;0.0214578685479017;IFI6;1
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;1/8;32/18862;0.0134944336544056;0.0470795853973604;0.0214578685479017;IFI6;1
GO:0001819;positive regulation of cytokine production;2/8;437/18862;0.0136706831222788;0.0470795853973604;0.0214578685479017;STAT1/IRF1;2
GO:0032728;positive regulation of interferon-beta production;1/8;33/18862;0.0139135544473299;0.0470795853973604;0.0214578685479017;IRF1;1
GO:0045589;regulation of regulatory T cell differentiation;1/8;33/18862;0.0139135544473299;0.0470795853973604;0.0214578685479017;IRF1;1
GO:0046640;regulation of alpha-beta T cell proliferation;1/8;34/18862;0.014332519424993;0.0479398063525629;0.0218499388693179;IRF1;1
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;1/8;35/18862;0.0147513286370498;0.0487799617429713;0.0222328637352664;IRF1;1
GO:0045066;regulatory T cell differentiation;1/8;36/18862;0.0151699821331407;0.0495530346084462;0.022585213820453;IRF1;1
GO:0046633;alpha-beta T cell proliferation;1/8;37/18862;0.0155884799628937;0.0495530346084462;0.022585213820453;IRF1;1
GO:1901223;negative regulation of NIK/NF-kappaB signaling;1/8;37/18862;0.0155884799628937;0.0495530346084462;0.022585213820453;IFI35;1
GO:0010463;mesenchymal cell proliferation;1/8;38/18862;0.0160068221759242;0.0495530346084462;0.022585213820453;STAT1;1
GO:0010742;macrophage derived foam cell differentiation;1/8;38/18862;0.0160068221759242;0.0495530346084462;0.022585213820453;STAT1;1
GO:0090077;foam cell differentiation;1/8;38/18862;0.0160068221759242;0.0495530346084462;0.022585213820453;STAT1;1
GO:0072210;metanephric nephron development;1/8;39/18862;0.0164250088218334;0.0503123954437213;0.0229313142554128;STAT1;1
GO:0032735;positive regulation of interleukin-12 production;1/8;40/18862;0.0168430399502095;0.0510554648490726;0.0232699894048947;IRF1;1
GO:0050691;regulation of defense response to virus by host;1/8;41/18862;0.017260915610628;0.0514448303312146;0.0234474538677267;STAT1;1
GO:0000266;mitochondrial fission;1/8;42/18862;0.0176786358526511;0.0514448303312146;0.0234474538677267;MX1;1
GO:0062208;positive regulation of pattern recognition receptor signaling pathway;1/8;42/18862;0.0176786358526511;0.0514448303312146;0.0234474538677267;IFI35;1
GO:2001239;regulation of extrinsic apoptotic signaling pathway in absence of ligand;1/8;42/18862;0.0176786358526511;0.0514448303312146;0.0234474538677267;IFI6;1
GO:0034142;toll-like receptor 4 signaling pathway;1/8;43/18862;0.0180962007258275;0.0516273961883903;0.0235306634825002;IFI35;1
GO:0048489;synaptic vesicle transport;1/8;43/18862;0.0180962007258275;0.0516273961883903;0.0235306634825002;MX1;1
GO:0003254;regulation of membrane depolarization;1/8;44/18862;0.0185136102796927;0.0523054426348599;0.0238397025573968;IFI6;1
GO:0071354;cellular response to interleukin-6;1/8;46/18862;0.019347963627568;0.0532554452637946;0.0242726934463307;STAT1;1
GO:0099637;neurotransmitter receptor transport;1/8;46/18862;0.019347963627568;0.0532554452637946;0.0242726934463307;MX1;1
GO:0030857;negative regulation of epithelial cell differentiation;1/8;47/18862;0.0197649075205836;0.0532554452637946;0.0242726934463307;STAT1;1
GO:0045581;negative regulation of T cell differentiation;1/8;47/18862;0.0197649075205836;0.0532554452637946;0.0242726934463307;IRF1;1
GO:0045646;regulation of erythrocyte differentiation;1/8;47/18862;0.0197649075205836;0.0532554452637946;0.0242726934463307;STAT1;1
GO:0035850;epithelial cell differentiation involved in kidney development;1/8;48/18862;0.0201816962922993;0.0538795745051292;0.0245571582117789;STAT1;1
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;1/8;49/18862;0.0205983299921858;0.0544919457066006;0.0248362639140231;STAT1;1
GO:0032648;regulation of interferon-beta production;1/8;50/18862;0.0210148086696994;0.0546009760971654;0.0248859576351703;IRF1;1
GO:0070741;response to interleukin-6;1/8;50/18862;0.0210148086696994;0.0546009760971654;0.0248859576351703;STAT1;1
GO:0032608;interferon-beta production;1/8;52/18862;0.0218473011553695;0.0562616339487833;0.0256428499820825;IRF1;1
GO:0045071;negative regulation of viral genome replication;1/8;54/18862;0.0226791741447021;0.057388171096594;0.026156301530732;MX1;1
GO:0097479;synaptic vesicle localization;1/8;54/18862;0.0226791741447021;0.057388171096594;0.026156301530732;MX1;1
GO:0001836;release of cytochrome c from mitochondria;1/8;55/18862;0.023094878451744;0.0574411079440811;0.0261804290141227;IFI6;1
GO:0045620;negative regulation of lymphocyte differentiation;1/8;55/18862;0.023094878451744;0.0574411079440811;0.0261804290141227;IRF1;1
GO:0061005;cell differentiation involved in kidney development;1/8;58/18862;0.0243410632148683;0.0595510919094435;0.0271421145979016;STAT1;1
GO:0048488;synaptic vesicle endocytosis;1/8;59/18862;0.0247561489144151;0.0595510919094435;0.0271421145979016;MX1;1
GO:0140238;presynaptic endocytosis;1/8;59/18862;0.0247561489144151;0.0595510919094435;0.0271421145979016;MX1;1
GO:0032615;interleukin-12 production;1/8;60/18862;0.0251710800854349;0.0595510919094435;0.0271421145979016;IRF1;1
GO:0032655;regulation of interleukin-12 production;1/8;60/18862;0.0251710800854349;0.0595510919094435;0.0271421145979016;IRF1;1
GO:0099072;regulation of postsynaptic membrane neurotransmitter receptor levels;1/8;60/18862;0.0251710800854349;0.0595510919094435;0.0271421145979016;MX1;1
GO:0070936;protein K48-linked ubiquitination;1/8;61/18862;0.0255858567772398;0.0600442284046514;0.0273668756700527;IFI27;1
GO:0051851;modulation by host of symbiont process;1/8;62/18862;0.0260004790391292;0.0605291152030927;0.0275878767067813;IFI27;1
GO:0038034;signal transduction in absence of ligand;1/8;67/18862;0.0280712756243989;0.0638182906773444;0.0290870125713344;IFI6;1
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;1/8;67/18862;0.0280712756243989;0.0638182906773444;0.0290870125713344;IFI6;1
GO:1901224;positive regulation of NIK/NF-kappaB signaling;1/8;67/18862;0.0280712756243989;0.0638182906773444;0.0290870125713344;IFI35;1
GO:0050688;regulation of defense response to virus;1/8;69/18862;0.0288985149731037;0.0646882142859475;0.0294835051547455;STAT1;1
GO:0072088;nephron epithelium morphogenesis;1/8;69/18862;0.0288985149731037;0.0646882142859475;0.0294835051547455;STAT1;1
GO:0051881;regulation of mitochondrial membrane potential;1/8;71/18862;0.029725138177822;0.064964605074795;0.029609478167568;IFI6;1
GO:0072028;nephron morphogenesis;1/8;71/18862;0.029725138177822;0.064964605074795;0.029609478167568;STAT1;1
GO:0098586;cellular response to virus;1/8;71/18862;0.029725138177822;0.064964605074795;0.029609478167568;IFI6;1
GO:0036465;synaptic vesicle recycling;1/8;72/18862;0.0301382188491317;0.064964605074795;0.029609478167568;MX1;1
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;1/8;72/18862;0.0301382188491317;0.064964605074795;0.029609478167568;IFI6;1
GO:0071260;cellular response to mechanical stimulus;1/8;74/18862;0.0309639185754271;0.0662536787165389;0.0301970103754166;IRF1;1
GO:0001937;negative regulation of endothelial cell proliferation;1/8;75/18862;0.0313765377286843;0.0666465144455995;0.0303760565026064;STAT1;1
GO:2000117;negative regulation of cysteine-type endopeptidase activity;1/8;80/18862;0.0334373283603103;0.0705091489336979;0.0321365627261564;IFI6;1
GO:0001656;metanephros development;1/8;82/18862;0.0342605697994905;0.0717253655514514;0.0326908882600213;STAT1;1
GO:0045069;regulation of viral genome replication;1/8;83/18862;0.0346719603980852;0.0720681462560199;0.0328471203771333;MX1;1
GO:0051899;membrane depolarization;1/8;87/18862;0.0363159897959395;0.0747373756299254;0.0340636980624728;IFI6;1
GO:0060993;kidney morphogenesis;1/8;88/18862;0.0367266141411661;0.0747373756299254;0.0340636980624728;STAT1;1
GO:0072080;nephron tubule development;1/8;88/18862;0.0367266141411661;0.0747373756299254;0.0340636980624728;STAT1;1
GO:0042058;regulation of epidermal growth factor receptor signaling pathway;1/8;89/18862;0.0371370853826104;0.0750478600440252;0.0342052102208254;IFI6;1
GO:0061326;renal tubule development;1/8;90/18862;0.0375474035692047;0.0753537547492315;0.034344630487984;STAT1;1
GO:0051702;biological process involved in interaction with symbiont;1/8;92/18862;0.0383675809735129;0.0764723702965223;0.0348544715404659;IFI27;1
GO:0051591;response to cAMP;1/8;93/18862;0.0387774402890275;0.0767635042456259;0.0349871641705511;STAT1;1
GO:0032091;negative regulation of protein binding;1/8;96/18862;0.0400061012755484;0.0776118364745639;0.0353738158646954;IFIT2;1
GO:0048661;positive regulation of smooth muscle cell proliferation;1/8;96/18862;0.0400061012755484;0.0776118364745639;0.0353738158646954;STAT1;1
GO:1901184;regulation of ERBB signaling pathway;1/8;96/18862;0.0400061012755484;0.0776118364745639;0.0353738158646954;IFI6;1
GO:0051817;modulation of process of other organism involved in symbiotic interaction;1/8;98/18862;0.040824444955061;0.0786749237213427;0.0358583483048985;IFI27;1
GO:0046634;regulation of alpha-beta T cell activation;1/8;101/18862;0.0420508159835261;0.0794552965933417;0.0362140255769978;IRF1;1
GO:1902106;negative regulation of leukocyte differentiation;1/8;101/18862;0.0420508159835261;0.0794552965933417;0.0362140255769978;IRF1;1
GO:0042116;macrophage activation;1/8;102/18862;0.0424593013239736;0.0794552965933417;0.0362140255769978;IFI35;1
GO:0045639;positive regulation of myeloid cell differentiation;1/8;102/18862;0.0424593013239736;0.0794552965933417;0.0362140255769978;STAT1;1
GO:0046822;regulation of nucleocytoplasmic transport;1/8;103/18862;0.0428676342445177;0.0794552965933417;0.0362140255769978;IFI27;1
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;1/8;103/18862;0.0428676342445177;0.0794552965933417;0.0362140255769978;IFI6;1
GO:1903707;negative regulation of hemopoiesis;1/8;105/18862;0.0436838430208872;0.0801918138842825;0.0365497144128038;IRF1;1
GO:0072009;nephron epithelium development;1/8;106/18862;0.044091718974176;0.0801918138842825;0.0365497144128038;STAT1;1
GO:1901222;regulation of NIK/NF-kappaB signaling;1/8;106/18862;0.044091718974176;0.0801918138842825;0.0365497144128038;IFI35;1
GO:0046632;alpha-beta T cell differentiation;1/8;107/18862;0.044499442702487;0.0804306697293398;0.0366585798006758;IRF1;1
GO:0006900;vesicle budding from membrane;1/8;109/18862;0.0453144336789612;0.0813981493862821;0.0370995363453483;MX1;1
GO:0031623;receptor internalization;1/8;111/18862;0.0461288163397453;0.0823526721157416;0.0375345873994699;MX1;1
GO:0030218;erythrocyte differentiation;1/8;115/18862;0.047755758270952;0.0847373515661405;0.0386214733128367;STAT1;1
GO:0050868;negative regulation of T cell activation;1/8;119/18862;0.0493802716074455;0.0870888426531312;0.0396932326796691;IRF1;1
GO:0034101;erythrocyte homeostasis;1/8;121/18862;0.0501916185240612;0.0879865119909747;0.0401023711733146;STAT1;1
GO:0007173;epidermal growth factor receptor signaling pathway;1/8;123/18862;0.0510023594572467;0.0883433726313024;0.0402650206241422;IFI6;1
GO:0035821;modulation of process of other organism;1/8;123/18862;0.0510023594572467;0.0883433726313024;0.0402650206241422;IFI27;1
GO:0046683;response to organophosphorus;1/8;130/18862;0.0538351862035484;0.0926984567173526;0.0422499748467587;STAT1;1
GO:0072073;kidney epithelium development;1/8;131/18862;0.054239271112281;0.0928448699627869;0.0423167068739777;STAT1;1
GO:0050729;positive regulation of inflammatory response;1/8;133/18862;0.0550469879439482;0.0936764531677716;0.0426957247210679;IFI35;1
GO:0072006;nephron development;1/8;138/18862;0.0570636398625737;0.0959856601156586;0.0437482118812552;STAT1;1
GO:1903038;negative regulation of leukocyte cell-cell adhesion;1/8;138/18862;0.0570636398625737;0.0959856601156586;0.0437482118812552;IRF1;1
GO:0014074;response to purine-containing compound;1/8;144/18862;0.0594786504849038;0.0983116691980299;0.0448083570951411;STAT1;1
GO:0002262;myeloid cell homeostasis;1/8;145/18862;0.0598806256316139;0.0983116691980299;0.0448083570951411;STAT1;1
GO:0038127;ERBB signaling pathway;1/8;145/18862;0.0598806256316139;0.0983116691980299;0.0448083570951411;IFI6;1
GO:0016525;negative regulation of angiogenesis;1/8;146/18862;0.0602824504430125;0.0983116691980299;0.0448083570951411;STAT1;1
GO:0045580;regulation of T cell differentiation;1/8;146/18862;0.0602824504430125;0.0983116691980299;0.0448083570951411;IRF1;1
GO:1903900;regulation of viral life cycle;1/8;148/18862;0.0610856492526407;0.0983116691980299;0.0448083570951411;MX1;1
GO:2000181;negative regulation of blood vessel morphogenesis;1/8;148/18862;0.0610856492526407;0.0983116691980299;0.0448083570951411;STAT1;1
GO:0046631;alpha-beta T cell activation;1/8;149/18862;0.0614870233472214;0.0983116691980299;0.0448083570951411;IRF1;1
GO:1901343;negative regulation of vasculature development;1/8;149/18862;0.0614870233472214;0.0983116691980299;0.0448083570951411;STAT1;1
GO:0051250;negative regulation of lymphocyte activation;1/8;153/18862;0.0630910187808104;0.100325062651453;0.0457260187885079;IRF1;1
GO:2001236;regulation of extrinsic apoptotic signaling pathway;1/8;154/18862;0.0634916426436438;0.100413413094024;0.0457662870314595;IFI6;1
GO:0030856;regulation of epithelial cell differentiation;1/8;156/18862;0.064292440711322;0.101130271605377;0.0460930158157984;STAT1;1
GO:0051100;negative regulation of binding;1/8;159/18862;0.0654925143888573;0.101992775064363;0.0464861264536433;IFIT2;1
GO:0048660;regulation of smooth muscle cell proliferation;1/8;160/18862;0.0658922395604816;0.101992775064363;0.0464861264536433;STAT1;1
GO:0050680;negative regulation of epithelial cell proliferation;1/8;160/18862;0.0658922395604816;0.101992775064363;0.0464861264536433;STAT1;1
GO:0048659;smooth muscle cell proliferation;1/8;162/18862;0.0666912411105064;0.102683339487605;0.0468008709547413;STAT1;1
GO:0007259;receptor signaling pathway via JAK-STAT;1/8;166/18862;0.0682874503812626;0.104587621373407;0.0476688019281944;STAT1;1
GO:0042129;regulation of T cell proliferation;1/8;168/18862;0.0690846588693048;0.10470643609879;0.0477229551399803;IRF1;1
GO:0043112;receptor metabolic process;1/8;168/18862;0.0690846588693048;0.10470643609879;0.0477229551399803;MX1;1
GO:0002819;regulation of adaptive immune response;1/8;170/18862;0.0698812704369888;0.105365024337636;0.0480231255798232;IRF1;1
GO:0061025;membrane fusion;1/8;172/18862;0.070677285467457;0.105727161351988;0.0481881798891317;MX1;1
GO:0033209;tumor necrosis factor-mediated signaling pathway;1/8;174/18862;0.0714727043436473;0.105727161351988;0.0481881798891317;STAT1;1
GO:0045619;regulation of lymphocyte differentiation;1/8;175/18862;0.0718701903435002;0.105727161351988;0.0481881798891317;IRF1;1
GO:0097696;receptor signaling pathway via STAT;1/8;175/18862;0.0718701903435002;0.105727161351988;0.0481881798891317;STAT1;1
GO:0001936;regulation of endothelial cell proliferation;1/8;177/18862;0.0726647157058335;0.105727161351988;0.0481881798891317;STAT1;1
GO:0001959;regulation of cytokine-mediated signaling pathway;1/8;177/18862;0.0726647157058335;0.105727161351988;0.0481881798891317;STAT1;1
GO:0099504;synaptic vesicle cycle;1/8;177/18862;0.0726647157058335;0.105727161351988;0.0481881798891317;MX1;1
GO:0002695;negative regulation of leukocyte activation;1/8;182/18862;0.0746484259572143;0.108073094296266;0.0492574059733386;IRF1;1
GO:0006611;protein export from nucleus;1/8;183/18862;0.0750447221345343;0.10810898089678;0.0492737623186624;IFI27;1
GO:0038061;NIK/NF-kappaB signaling;1/8;185/18862;0.0758368689980566;0.108711964918396;0.0495485895450098;IFI35;1
GO:0007219;Notch signaling pathway;1/8;186/18862;0.0762327197796605;0.108743732626869;0.0495630685873954;STAT1;1
GO:0022408;negative regulation of cell-cell adhesion;1/8;189/18862;0.0774193820959865;0.109364272766661;0.0498458975170889;IRF1;1
GO:0060759;regulation of response to cytokine stimulus;1/8;189/18862;0.0774193820959865;0.109364272766661;0.0498458975170889;STAT1;1
GO:0001935;endothelial cell proliferation;1/8;191/18862;0.0782097490929964;0.109947038580009;0.0501115097163364;STAT1;1
GO:0099003;vesicle-mediated transport in synapse;1/8;194/18862;0.079394188720188;0.111075523642186;0.050625849082711;MX1;1
GO:0042098;T cell proliferation;1/8;195/18862;0.0797887058880816;0.111093365614506;0.0506339810722653;IRF1;1
GO:0043393;regulation of protein binding;1/8;196/18862;0.080183075114679;0.111110832658912;0.050641942177692;IFIT2;1
GO:0050866;negative regulation of cell activation;1/8;200/18862;0.0817590735590016;0.112757774434452;0.0513925830303527;IRF1;1
GO:0051168;nuclear export;1/8;201/18862;0.0821527037921774;0.112766211337376;0.0513964283903394;IFI27;1
GO:0009612;response to mechanical stimulus;1/8;202/18862;0.0825461863691919;0.112774367293121;0.0514001457006087;IRF1;1
GO:0043281;regulation of cysteine-type endopeptidase activity involved in apoptotic process;1/8;205/18862;0.0837257486379797;0.11385136847501;0.05189101981498;IFI6;1
GO:0051650;establishment of vesicle localization;1/8;209/18862;0.0852964340223035;0.115447731630187;0.0526186080137588;MX1;1
GO:0050803;regulation of synapse structure or activity;1/8;214/18862;0.0872564773819685;0.117553865361819;0.053578538743314;MX1;1
GO:0050670;regulation of lymphocyte proliferation;1/8;221/18862;0.0899943637312242;0.119500778046345;0.0544658999234564;IRF1;1
GO:0033002;muscle cell proliferation;1/8;222/18862;0.0903849031384527;0.119500778046345;0.0544658999234564;STAT1;1
GO:0032944;regulation of mononuclear cell proliferation;1/8;223/18862;0.090775295883887;0.119500778046345;0.0544658999234564;IRF1;1
GO:0045089;positive regulation of innate immune response;1/8;223/18862;0.090775295883887;0.119500778046345;0.0544658999234564;IFI35;1
GO:0051648;vesicle localization;1/8;224/18862;0.0911655420147377;0.119500778046345;0.0544658999234564;MX1;1
GO:2001234;negative regulation of apoptotic signaling pathway;1/8;224/18862;0.0911655420147377;0.119500778046345;0.0544658999234564;IFI6;1
GO:0098657;import into cell;1/8;230/18862;0.0935039425358291;0.121435158366514;0.0553475491198435;MX1;1
GO:2000116;regulation of cysteine-type endopeptidase activity;1/8;230/18862;0.0935039425358291;0.121435158366514;0.0553475491198435;IFI6;1
GO:0048762;mesenchymal cell differentiation;1/8;231/18862;0.0938931636854488;0.121435158366514;0.0553475491198435;STAT1;1
GO:0007050;cell cycle arrest;1/8;235/18862;0.0954485863813491;0.122900613437932;0.0560154722126222;IRF1;1
GO:0070663;regulation of leukocyte proliferation;1/8;241/18862;0.0977773398943526;0.125344519424038;0.0571293523148084;IRF1;1
GO:0043122;regulation of I-kappaB kinase/NF-kappaB signaling;1/8;244/18862;0.0989397481625509;0.12615983482882;0.0575009556463423;STAT1;1
GO:0010951;negative regulation of endopeptidase activity;1/8;245/18862;0.0993269262705483;0.12615983482882;0.0575009556463423;IFI6;1
GO:0030217;T cell differentiation;1/8;246/18862;0.099713958799411;0.12615983482882;0.0575009556463423;IRF1;1
GO:0033157;regulation of intracellular protein transport;1/8;248/18862;0.100487587307401;0.126527531739986;0.0576685440377581;IFI27;1
GO:0048872;homeostasis of number of cells;1/8;249/18862;0.100874183380332;0.126527531739986;0.0576685440377581;STAT1;1
GO:0010466;negative regulation of peptidase activity;1/8;257/18862;0.103961721804289;0.129212681755593;0.0588923780112308;IFI6;1
GO:0002833;positive regulation of response to biotic stimulus;1/8;258/18862;0.10434701103974;0.129212681755593;0.0588923780112308;IFI35;1
GO:0045637;regulation of myeloid cell differentiation;1/8;258/18862;0.10434701103974;0.129212681755593;0.0588923780112308;STAT1;1
GO:1902105;regulation of leukocyte differentiation;1/8;279/18862;0.112404668793793;0.137001174257802;0.0624422063898824;IRF1;1
GO:0001822;kidney development;1/8;280/18862;0.112786779467508;0.137001174257802;0.0624422063898824;STAT1;1
GO:0072593;reactive oxygen species metabolic process;1/8;281/18862;0.11316874619683;0.137001174257802;0.0624422063898824;IFI6;1
GO:0007249;I-kappaB kinase/NF-kappaB signaling;1/8;282/18862;0.11355056902824;0.137001174257802;0.0624422063898824;STAT1;1
GO:0046651;lymphocyte proliferation;1/8;282/18862;0.11355056902824;0.137001174257802;0.0624422063898824;IRF1;1
GO:0031503;protein-containing complex localization;1/8;283/18862;0.113932248008206;0.137001174257802;0.0624422063898824;MX1;1
GO:0097193;intrinsic apoptotic signaling pathway;1/8;283/18862;0.113932248008206;0.137001174257802;0.0624422063898824;IFI6;1
GO:0032943;mononuclear cell proliferation;1/8;285/18862;0.11469517459962;0.13735101155757;0.0626016547522294;IRF1;1
GO:0060485;mesenchyme development;1/8;287/18862;0.115457526342572;0.137587753664149;0.062709556743291;STAT1;1
GO:0072001;renal system development;1/8;288/18862;0.115838486761913;0.137587753664149;0.062709556743291;STAT1;1
GO:0051258;protein polymerization;1/8;294/18862;0.118121235870086;0.139493437772529;0.0635781268198177;MX1;1
GO:0007162;negative regulation of cell adhesion;1/8;295/18862;0.118501192252736;0.139493437772529;0.0635781268198177;IRF1;1
GO:0071356;cellular response to tumor necrosis factor;1/8;296/18862;0.118881005386897;0.139493437772529;0.0635781268198177;STAT1;1
GO:0071496;cellular response to external stimulus;1/8;303/18862;0.121535690255471;0.142035686202177;0.0647368293053873;IRF1;1
GO:0070661;leukocyte proliferation;1/8;312/18862;0.124938571476723;0.145428497198906;0.0662832000255459;IRF1;1
GO:0001655;urogenital system development;1/8;320/18862;0.127953666238038;0.147756019346306;0.0673440348621254;STAT1;1
GO:0034612;response to tumor necrosis factor;1/8;320/18862;0.127953666238038;0.147756019346306;0.0673440348621254;STAT1;1
GO:0050863;regulation of T cell activation;1/8;327/18862;0.130584413365297;0.149134384943937;0.0679722644345672;IRF1;1
GO:0006898;receptor-mediated endocytosis;1/8;328/18862;0.130959666923057;0.149134384943937;0.0679722644345672;MX1;1
GO:0071214;cellular response to abiotic stimulus;1/8;330/18862;0.131709748902378;0.149134384943937;0.0679722644345672;IRF1;1
GO:0104004;cellular response to environmental stimulus;1/8;330/18862;0.131709748902378;0.149134384943937;0.0679722644345672;IRF1;1
GO:1903037;regulation of leukocyte cell-cell adhesion;1/8;330/18862;0.131709748902378;0.149134384943937;0.0679722644345672;IRF1;1
GO:0045765;regulation of angiogenesis;1/8;335/18862;0.133582476029899;0.150315655069445;0.0685106621043592;STAT1;1
GO:0000209;protein polyubiquitination;1/8;337/18862;0.134330576715116;0.150315655069445;0.0685106621043592;IFI27;1
GO:0016050;vesicle organization;1/8;339/18862;0.135078112140911;0.150315655069445;0.0685106621043592;MX1;1
GO:0006913;nucleocytoplasmic transport;1/8;340/18862;0.135451667995949;0.150315655069445;0.0685106621043592;IFI27;1
GO:1901342;regulation of vasculature development;1/8;341/18862;0.135825082673415;0.150315655069445;0.0685106621043592;STAT1;1
GO:0007596;blood coagulation;1/8;342/18862;0.136198356219045;0.150315655069445;0.0685106621043592;IRF1;1
GO:0051169;nuclear transport;1/8;343/18862;0.136571488678562;0.150315655069445;0.0685106621043592;IFI27;1
GO:0007599;hemostasis;1/8;346/18862;0.137690039997477;0.150315655069445;0.0685106621043592;IRF1;1
GO:0045861;negative regulation of proteolysis;1/8;346/18862;0.137690039997477;0.150315655069445;0.0685106621043592;IFI6;1
GO:0050817;coagulation;1/8;347/18862;0.138062608569524;0.150315655069445;0.0685106621043592;IRF1;1
GO:2001233;regulation of apoptotic signaling pathway;1/8;348/18862;0.138435036283888;0.150315655069445;0.0685106621043592;IFI6;1
GO:0032386;regulation of intracellular transport;1/8;350/18862;0.139179469322149;0.150562176850355;0.0686230214619089;IFI27;1
GO:0051098;regulation of binding;1/8;357/18862;0.141780554645439;0.152642467530869;0.0695711734812427;IFIT2;1
GO:0030098;lymphocyte differentiation;1/8;358/18862;0.142151576291634;0.152642467530869;0.0695711734812427;IRF1;1
GO:0031349;positive regulation of defense response;1/8;361/18862;0.143263799274932;0.153271197018401;0.0698577349405627;IFI35;1
GO:0007159;leukocyte cell-cell adhesion;1/8;366/18862;0.145114700458807;0.154118167275595;0.0702437658771023;IRF1;1
GO:0050727;regulation of inflammatory response;1/8;366/18862;0.145114700458807;0.154118167275595;0.0702437658771023;IFI35;1
GO:0050678;regulation of epithelial cell proliferation;1/8;374/18862;0.148068865104585;0.156683780892488;0.0714131177155127;STAT1;1
GO:0002683;negative regulation of immune system process;1/8;403/18862;0.158702970573419;0.167328132017627;0.0762645854014142;IRF1;1
GO:1903131;mononuclear cell differentiation;1/8;411/18862;0.161615998823815;0.1697843164539;0.0773840617586956;IRF1;1
GO:0030099;myeloid cell differentiation;1/8;419/18862;0.164520197573178;0.172213588107176;0.0784912718448333;STAT1;1
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;1/8;425/18862;0.166692566082443;0.173616988043647;0.0791309115337295;IFI27;1
GO:0052548;regulation of endopeptidase activity;1/8;426/18862;0.167054146571207;0.173616988043647;0.0791309115337295;IFI6;1
GO:0050673;epithelial cell proliferation;1/8;428/18862;0.167776895725862;0.173633417866014;0.0791383998955244;STAT1;1
GO:0042391;regulation of membrane potential;1/8;431/18862;0.168859990570728;0.173633417866014;0.0791383998955244;IFI6;1
GO:0051656;establishment of organelle localization;1/8;431/18862;0.168859990570728;0.173633417866014;0.0791383998955244;MX1;1
GO:0043434;response to peptide hormone;1/8;435/18862;0.170302198316182;0.174499787711299;0.0795332727495883;STAT1;1
GO:0022407;regulation of cell-cell adhesion;1/8;437/18862;0.171022480685686;0.17462295396328;0.0795894092941697;IRF1;1
GO:0052547;regulation of peptidase activity;1/8;455/18862;0.177480441031822;0.180316499546443;0.0821844056532894;IFI6;1
GO:0051346;negative regulation of hydrolase activity;1/8;456/18862;0.17783792223309;0.180316499546443;0.0821844056532894;IFI6;1
GO:0002697;regulation of immune effector process;1/8;465/18862;0.181049140432706;0.18293506897888;0.0833778936203253;STAT1;1
GO:0042110;T cell activation;1/8;474/18862;0.184249378630603;0.185524460835659;0.0845580830721398;IRF1;1
GO:0010498;proteasomal protein catabolic process;1/8;483/18862;0.187438669022674;0.188085009260683;0.0857251263043808;IFI27;1
GO:0048285;organelle fission;1/8;486/18862;0.188499338527674;0.188499338527674;0.0859139687266665;MX1;1
